This grant, offered by the Ovarian Cancer Research Program (OCRP), is specifically designed to support the rapid implementation of clinical trials that hold significant potential to advance the treatment or management of ovarian cancer. Funding is available for diverse trial designs focused on evaluating promising new products, pharmacologic agents (drugs or biologics), medical devices, innovative clinical guidance, and/or emerging approaches and technologies. Projects supported can range from smaller proof-of-concept studies, such as pilot or first-in-human trials, which aim to demonstrate feasibility, to larger-scale trials focused on determining efficacy in relevant patient populations. The primary objective is to accelerate impactful advancements in ovarian cancer care.
Opportunity ID: 346665
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | HT9425-23-OCRP-CTA |
| Funding Opportunity Title: | Ovarian Cancer Clinical Trial Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 2 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 07, 2023 |
| Last Updated Date: | Mar 07, 2023 |
| Original Closing Date for Applications: | Jul 21, 2023 |
| Current Closing Date for Applications: | Jul 21, 2023 |
| Archive Date: | Aug 20, 2023 |
| Estimated Total Program Funding: | $6,400,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: |
The OCRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of ovarian cancer. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first in human, phase 0) to demonstrate the feasibility or inform the design of more advanced trials through large-scale trials to determine efficacy in relevant patient populations. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507 Email: help@eBRAP.org Email:help@eBRAP.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 346665 Full Announcement-FY23 OCRP CTA -> HT9425-23-OCRP-CTA_GG.pdf
Packages
| Agency Contact Information: | CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org Email: help@eBRAP.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00280392 | Mar 07, 2023 | Jul 21, 2023 | View |
Package 1
Mandatory forms
346665 RR_SF424_5_0-5.0.pdf
346665 AttachmentForm_1_2-1.2.pdf
346665 RR_PersonalData_1_2-1.2.pdf
346665 RR_KeyPersonExpanded_4_0-4.0.pdf
346665 RR_Budget_3_0-3.0.pdf
346665 PerformanceSite_4_0-4.0.pdf
Optional forms
346665 RR_SubawardBudget30_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
